depressive disorder

Chattin With Catherine: Interview of Psychiatrist & TMS Expert Kira Stein, MD


 

Chattin With Catherine: Interview of Psychiatrist & TMS Expert Kira Stein, MD – West Coast TMS Institute’s director Kira Stein, MD discusses how transcranial magnetic stimulation, an effective, non-invasive, FDA-approved, office-based treatment for clinical depression with few side effects.… Continue reading

Surgical Versus Low-Dose Progestin Treatment for Endometriosis-Associated Severe Deep Dyspareunia II: Effect on Sexual Functioning, Psychological Status and Health-Related Quality of Life.

Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: Effect on sexual functioning, psychological status and health-related quality of life.

Hum Reprod. 2013 Feb 26;
Vercellini P, Frattaruolo MP, Somigliana E, Jones GL, Consonni D, Alberico D,… Continue reading

Gene-Environment Interactions in Major Depressive Disorder.

Gene-environment interactions in major depressive disorder.

Can J Psychiatry. 2013 Feb; 58(2): 76-83
Klengel T, Binder EB

Family, twin, and epidemiologic studies have suggested that both genes and environment are important risk factors for the development of major depressive… Continue reading

[Remission, Response, and Its Prediction in Depressive Inpatients.]

[Remission, Response, and its Prediction in Depressive Inpatients.]

Psychother Psychosom Med Psychol. 2013 Feb 26;
Harbeck S, Kliem S, Wollburg E, Braukhaus C, Kröger C

Using mean comparisons and effect sizes to report effects of inpatient treatment, this not… Continue reading

Acute Psychological Stress Results in the Rapid Development of Insulin Resistance.

Acute Psychological Stress Results in the Rapid Development of Insulin Resistance.

J Endocrinol. 2013 Feb 26;
Li L, Li X, Zhou W, Messina J

In recent years, the roles of chronic stress and depression as an independent risk factor… Continue reading

Using the High-Risk Family Design to Identify Biomarkers for Major Depression.

Using the high-risk family design to identify biomarkers for major depression.

Philos Trans R Soc Lond B Biol Sci. 2013; 368(1615): 20120129
Talati A, Weissman MM, Hamilton SP

The familial nature of major depressive disorder (MDD) is now well… Continue reading

Anxiety and Affective Disorder Comorbidity Related to Serotonin and Other Neurotransmitter Systems: Obsessive-Compulsive Disorder as an Example of Overlapping Clinical and Genetic Heterogeneity.

Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Philos Trans R Soc Lond B Biol Sci. 2013; 368(1615): 20120435
Murphy DL, Moya PR, Fox… Continue reading

The Serotonergic System in Mood Disorders and Suicidal Behaviour.

The serotonergic system in mood disorders and suicidal behaviour.

Philos Trans R Soc Lond B Biol Sci. 2013; 368(1615): 20120537
Mann JJ

A stress-diathesis explanatory model of suicidal behaviour has proved to be of heuristic value, and both clinical… Continue reading

Validation of a Dutch Version of the Neurological Fatigue Index (NFI-MS) for Patients With Multiple Sclerosis in the Netherlands.

Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands.

Qual Life Res. 2013 Feb 26;
Derksen A, Mokkink LB, Rietberg MB, Knol DL, Ostelo RW, Uitdehaag BM

PURPOSE: Fatigue… Continue reading

Imaging Dopamine Transmission in the Frontal Cortex: A Simultaneous Microdialysis and [(11)C]FLB 457 PET Study.

Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [(11)C]FLB 457 PET study.

Mol Psychiatry. 2013 Feb 26;
Narendran R, Jedema HP, Lopresti BJ, Mason NS, Gurnsey K, Ruszkiewicz J, Chen CM, Deuitch L, Frankle WG, Bradberry… Continue reading